COVID-19: CDC, FDA and CMS Guidance
This page includes AHA Today stories and other AHA content on coronavirus COVID-19 guidance from the CDC, FDA, and CMS.
New evidence suggests breast milk is not a likely source of SARS-CoV-2 transmission, according to a recent update from the Centers for Disease Control and Prevention (CDC)
This week the Food and Drug Administration (FDA) granted emergency use authorization for the first rapid home-based test for SARS-CoV-2.
Hospitalization rates are roughly four times higher for Black, Hispanic and Native American people infected with COVID-19 than for whites
In a study of 106,543 patients hospitalized for COVID-19 between March and July, 9% were readmitted to the same hospital
Last week, the Food and Drug Administration (FDA) issued an emergency use authorization (EAU) for the first serology test
EvergreenHealth is located in Kirkland, Wash., just outside of Seattle and was the first hospital in the country to treat a wave of patients diagnosed with community-spread COVID-19.
Coverage for telehealth services, which was approved on an emergency basis during the COVID-19 pandemic, will become standard for patients receiving home-based health
The American Hospital Association (AHA) delivered comments to the Centers for Medicare & Medicaid Services
The American Hospital Association’s (AHA) Center for Health Innovation partnered with the Centers for Disease Control and Prevention.
In its Morbidity and Mortality Weekly Report (MMWR), the Centers for Disease Control and Prevention (CDC) reported early increases in the rate of positive test results for Americans younger than age 25 living in 767 COVID-19 hotspot counties in June and July.